Literature DB >> 27720142

Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management.

Stephen E Asche1, Patrick J O'Connor1, Steven P Dehmer1, Beverly B Green2, Anna R Bergdall1, Michael V Maciosek1, Rachel A Nyboer1, Pamala A Pawloski1, JoAnn M Sperl-Hillen1, Nicole K Trower1, Karen L Margolis3.   

Abstract

This paper reports subgroup analysis of a successful cluster-randomized trial to identify attributes of hypertensive patients who benefited more or less from an intervention combining blood pressure (BP) telemonitoring and pharmacist management. The end point was BP < 140/90 mm Hg at 6-month follow-up. Fourteen baseline patient characteristics were selected a priori as subgroup variables. Among the 351 trial participants, 44% were female, 84% non-Hispanic white, mean age was 60.9 years, and mean BP was 149/86 mm Hg. The overall adjusted odds ratio for BP control in the intervention versus usual care group was 3.64 (P < .001). The effect of the intervention was significantly larger in patients who were younger (interaction P = .02), did not have diabetes (P = .005), had high baseline diastolic BP (P = .02), added salt less than daily in food preparation (P = .007), and took 0-2 (rather than 3-6) antihypertensive medication classes at baseline (P = .02). These findings may help prioritize patients for whom the intervention is most effective.
Copyright © 2016 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Case management; hypertension; moderators; subgroups

Mesh:

Substances:

Year:  2016        PMID: 27720142      PMCID: PMC5107124          DOI: 10.1016/j.jash.2016.09.004

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  21 in total

1.  Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

2.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Tatiana Nwankwo; Sung Sug Yoon; Vicki Burt; Quiping Gu
Journal:  NCHS Data Brief       Date:  2013-10

3.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

Review 4.  Interventions used to improve control of blood pressure in patients with hypertension.

Authors:  Liam G Glynn; Andrew W Murphy; Susan M Smith; Knut Schroeder; Tom Fahey
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

5.  Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): a cluster randomized trial.

Authors:  Karen L Margolis; Tessa J Kerby; Stephen E Asche; Anna R Bergdall; Michael V Maciosek; Patrick J O'Connor; JoAnn M Sperl-Hillen
Journal:  Contemp Clin Trials       Date:  2012-04-01       Impact factor: 2.226

Review 6.  Team-based care and improved blood pressure control: a community guide systematic review.

Authors:  Krista K Proia; Anilkrishna B Thota; Gibril J Njie; Ramona K C Finnie; David P Hopkins; Qaiser Mukhtar; Nicolaas P Pronk; Donald Zeigler; Thomas E Kottke; Kimberly J Rask; Daniel T Lackland; Joy F Brooks; Lynne T Braun; Tonya Cooksey
Journal:  Am J Prev Med       Date:  2014-06-02       Impact factor: 5.043

7.  Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial.

Authors:  Beverly B Green; Andrea J Cook; James D Ralston; Paul A Fishman; Sheryl L Catz; James Carlson; David Carrell; Lynda Tyll; Eric B Larson; Robert S Thompson
Journal:  JAMA       Date:  2008-06-25       Impact factor: 56.272

Review 8.  The potency of team-based care interventions for hypertension: a meta-analysis.

Authors:  Barry L Carter; Meaghan Rogers; Jeanette Daly; Shimin Zheng; Paul A James
Journal:  Arch Intern Med       Date:  2009-10-26

9.  Racial differences in the effect of a telephone-delivered hypertension disease management program.

Authors:  George L Jackson; Eugene Z Oddone; Maren K Olsen; Benjamin J Powers; Janet M Grubber; Felicia McCant; Hayden B Bosworth
Journal:  J Gen Intern Med       Date:  2012-08-03       Impact factor: 5.128

10.  Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.

Authors:  Benjamin Kasenda; Stefan Schandelmaier; Xin Sun; Erik von Elm; John You; Anette Blümle; Yuki Tomonaga; Ramon Saccilotto; Alain Amstutz; Theresa Bengough; Joerg J Meerpohl; Mihaela Stegert; Kelechi K Olu; Kari A O Tikkinen; Ignacio Neumann; Alonso Carrasco-Labra; Markus Faulhaber; Sohail M Mulla; Dominik Mertz; Elie A Akl; Dirk Bassler; Jason W Busse; Ignacio Ferreira-González; Francois Lamontagne; Alain Nordmann; Viktoria Gloy; Heike Raatz; Lorenzo Moja; Rachel Rosenthal; Shanil Ebrahim; Per O Vandvik; Bradley C Johnston; Martin A Walter; Bernard Burnand; Matthias Schwenkglenks; Lars G Hemkens; Heiner C Bucher; Gordon H Guyatt; Matthias Briel
Journal:  BMJ       Date:  2014-07-16
View more
  9 in total

Review 1.  Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care.

Authors:  Catherine G Derington; Jordan B King; Kelsey B Bryant; Blake T McGee; Andrew E Moran; William S Weintraub; Brandon K Bellows; Adam P Bress
Journal:  Curr Hypertens Rep       Date:  2019-11-07       Impact factor: 5.369

Review 2.  Physician-pharmacist collaborative practice and telehealth may transform hypertension management.

Authors:  Stefano Omboni; Mauro Tenti; Claudio Coronetti
Journal:  J Hum Hypertens       Date:  2018-12-13       Impact factor: 3.012

3.  Iranian Study on Social Determinants of Self-management in Patients with Hypertension Referring to Tabriz Health Care Centers in 2017-2018.

Authors:  Mohammad Zakaria Pezeshki; Fatemeh Keyghobadi Khajeh; Saeideh Ghaffarifar; Mahasti Alizadeh; Gholamreza Faridaalee
Journal:  Int J Prev Med       Date:  2020-05-19

4.  Assessment of willingness to Tele-monitoring interventions in patients with type 2 diabetes and/or hypertension in the public primary healthcare setting.

Authors:  David Yang Ern Sin; Xiaoxuan Guo; Dayna Wei Wei Yong; Tian Yu Qiu; Peter Kirm Seng Moey; Muller-Riemenschneider Falk; Ngiap Chuan Tan
Journal:  BMC Med Inform Decis Mak       Date:  2020-01-28       Impact factor: 2.796

5.  Continuity of Care and the Control of High Blood Pressure at Colombian Primary Care Services.

Authors:  Lena Barrera; Diana Oviedo; Alvaro Silva; Diego Tovar; Fabián Méndez
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

Review 6.  Rapid review: Identification of digital health interventions in atherosclerotic-related cardiovascular disease populations to address racial, ethnic, and socioeconomic health disparities.

Authors:  Kelly J Thomas Craig; Nicole Fusco; Kristina Lindsley; Jane L Snowdon; Van C Willis; Yull E Arriaga; Irene Dankwa-Mullan
Journal:  Cardiovasc Digit Health J       Date:  2020-11-06

7.  Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.

Authors:  Karen L Margolis; Stephen E Asche; Steven P Dehmer; Anna R Bergdall; Beverly B Green; JoAnn M Sperl-Hillen; Rachel A Nyboer; Pamala A Pawloski; Michael V Maciosek; Nicole K Trower; Patrick J O'Connor
Journal:  JAMA Netw Open       Date:  2018-09-07

Review 8.  The current state and future of internet technology-based hypertension management in Japan.

Authors:  Junichi Yatabe; Midori Sasaki Yatabe; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-12-23       Impact factor: 3.872

9.  Home blood pressure telemonitoring for improving blood pressure control in middle-aged and elderly patients with hypertension.

Authors:  Jianwei Yue; Xiaomin Yang; Bin Wang; Han Hu; Haiming Fu; Yuxia Gao; Gang Sun
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-08-05       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.